Filing Details

Accession Number:
0001209191-15-010389
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-06 16:59:21
Reporting Period:
2015-02-04
Filing Date:
2015-02-06
Accepted Time:
2015-02-06 16:59:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1454189 Auspex Pharmaceuticals Inc. ASPX Pharmaceutical Preparations (2834) 954862842
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405712 Cmea Ventures Vii Lp One Letterman Drive
Building C, Suite Cm500
San Francisco CA 94129
No No Yes No
1405972 Cmea Ventures Vii (Parallel) Lp One Letterman Drive
Building C, Suite Cm500
San Francisco CA 94129
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-04 48,750 $59.30 3,209,271 No 4 S Direct
Common Stock Disposition 2015-02-05 12,578 $59.51 3,196,693 No 4 S Direct
Common Stock Disposition 2015-02-06 29,522 $59.48 3,167,171 No 4 S Direct
Common Stock Disposition 2015-02-04 1,250 $59.30 82,339 No 4 S Indirect By: CMEA Ventures VII (Parallel) LP
Common Stock Disposition 2015-02-05 322 $59.51 82,017 No 4 S Indirect By: CMEA Ventures VII (Parallel) LP
Common Stock Disposition 2015-02-06 757 $59.48 81,260 No 4 S Indirect By: CMEA Ventures VII (Parallel) LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect By: CMEA Ventures VII (Parallel) LP
No 4 S Indirect By: CMEA Ventures VII (Parallel) LP
No 4 S Indirect By: CMEA Ventures VII (Parallel) LP